4.5 Article

Distinct functional roles for the two SLX4 ubiquitin-binding UBZ domains mutated in Fanconi anemia

Journal

JOURNAL OF CELL SCIENCE
Volume 127, Issue 13, Pages 2811-2817

Publisher

COMPANY OF BIOLOGISTS LTD
DOI: 10.1242/jcs.146167

Keywords

SLX4; FANCP; Ubiquitin; Fanconi anemia; UBZ; ICL

Categories

Funding

  1. Marie Curie Intra-European fellowship (FanDamAge)
  2. Medical Research Council (MRC)
  3. Division of Signal Transduction Therapy Unit (AstraZeneca)
  4. Division of Signal Transduction Therapy Unit (Boehringer-Ingelheim)
  5. Division of Signal Transduction Therapy Unit (GlaxoSmithKline)
  6. Division of Signal Transduction Therapy Unit (Merck KgaA)
  7. Division of Signal Transduction Therapy Unit (Janssen Pharmaceutica)
  8. Division of Signal Transduction Therapy Unit (Pfizer)
  9. MRC Protein Phosphorylation and Ubiquitylation Unit
  10. Medical Research Council [MC_UU_12016/1, MC_U127070192] Funding Source: researchfish
  11. MRC [MC_U127070192, MC_UU_12016/1] Funding Source: UKRI

Ask authors/readers for more resources

Defects in SLX4, a scaffold for DNA repair nucleases, result in Fanconi anemia (FA), due to the defective repair of inter-strand DNA crosslinks (ICLs). Some FA patients have an SLX4 deletion removing two tandem UBZ4-type ubiquitin-binding domains that are implicated in protein recruitment to sites of DNA damage. Here, we show that human SLX4 is recruited to sites of ICL induction but that the UBZ-deleted form of SLX4 in cells from FA patients is not. SLX4 recruitment does not require either the ubiquitylation of FANCD2 or the E3 ligases RNF8, RAD18 and BRCA1. We show that the first (UBZ-1) but not the second UBZ domain of SLX4 binds to ubiquitin polymers, with a preference for K63-linked chains. Furthermore, UBZ-1 is required for SLX4 recruitment to ICL sites and for efficient ICL repair in murine fibroblasts. The SLX4 UBZ-2 domain does not bind to ubiquitin in vitro or contribute to ICL repair, but it is required for the resolution of Holliday junctions in vivo. These data shed light on SLX4 recruitment, and they point to the existence of currently unidentified ubiquitylated ligands and E3 ligases that are crucial for ICL repair.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available